Human in Motion Robotics
Human in Motion Robotics develops the XoMotion self-balancing, hands-free lower-limb exoskeleton for individuals with spinal cord injuries and other lower-extremity motor deficits, selling XoMotion-R to rehabilitation centers starting in early 2025 with its first commercial sale to Synaptic Health in Calgary.
- Company typePrivate
- Founded2016
- HeadquartersVancouver, Canada
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Human in Motion Robotics does
Human in Motion Robotics (HMR) is a privately held Canadian medical-robotics company founded in 2016 in Vancouver, with a regional office in Seoul, South Korea. The company develops the XoMotion™ platform, a self-balancing, hands-free lower-limb exoskeleton designed for individuals with spinal cord injuries, stroke, and other lower-extremity motor deficits. The technology combines advanced sensor systems and multi-modal controllers that mimic physiological lower-extremity motion, enabling complex mobility tasks without external support. Key product variants include XoMotion-R for clinical ambulatory training at rehabilitation centers (commercially launched early 2025), a planned Therapeutic Recovery version for neurological conditions, and a planned Personal Mobility version for daily home and community use.
The company's go-to-market is enterprise field sales targeting rehabilitation centers and healthcare providers, with the first commercial sale completed to Synaptic Health in Calgary, Canada in February 2025. Revenue is generated via hardware unit sales in the medical-exoskeleton price band of USD 70,000–150,000 per system under multi-year contracts; specific XoMotion pricing is not publicly disclosed. HMR is not yet FDA-cleared, restricting U.S. commercial deployment until regulatory milestones are achieved.
The company is led by co-founder co-CEOs Dr. Siamak Arzanpour and Dr. Edward Park (academic collaborators from Simon Fraser University, where early prototypes were developed), supported by a CTO, VP of Engineering/CINO, VP of Sales & Marketing, Director of Quality & Regulatory, and a Director of Lived Experience. Cumulative disclosed funding totals approximately USD 16 million across multiple tranches since 2017, including a Series A led by Korean-based Beno Holdings in 2023 and a 2026 grant from Pacific Economic Development Canada. Third-party validation includes the CES 2025 Innovation Award, the TAG Award for MedTech Innovation, and a June 2025 IEEE Spectrum cover story.
Human in Motion Robotics firmographics
Firmographics- Name
- Human in Motion Robotics
- Legal name
- Human In Motion Robotics Inc.
- Website
- https://humaninmotion.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Human in Motion Robotics develops the XoMotion self-balancing, hands-free lower-limb exoskeleton for individuals with spinal cord injuries and other lower-extremity motor deficits, selling XoMotion-R to rehabilitation centers starting in early 2025 with its first commercial sale to Synaptic Health in Calgary.
- Ownership category
- akta.pro rank
Human in Motion Robotics industry classification
Industry- Product category
- Medical Exoskeletons
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN), Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics) (HLAHAMAJ)
Keywords
Where Human in Motion Robotics is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Human in Motion Robotics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of XoMotion exoskeleton systems to rehabilitation centers for clinical use (XoMotion-R model available early 2025). Hardware sales model with unit pricing in the medical exoskeleton market range of USD 70,000 to $150,000 per unit.
- Future Personal Mobility Device Sales: Planned availability of XoMotion platform for daily, personal use for individuals to independently perform mobility tasks at home and in their community
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | XoMotion-R for Rehabilitation Centers |
| Unit Pricing | Multi-year contract | XoMotion Therapeutic Recovery |
| Unit Pricing | Multi-year contract | XoMotion Personal Mobility |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels9 records
Human in Motion Robotics product offering
Product offeringCore offering
Human in Motion Robotics designs, develops, and manufactures the XoMotion platform — a next-generation, self-balancing, hands-free lower-limb exoskeleton for individuals with lower extremity motor deficits. The clinical version (XoMotion-R) is sold to rehabilitation centers for ambulatory training of spinal cord injury patients, with future variants planned for therapeutic recovery and daily personal mobility. The company operates from Vancouver, Canada and Seoul, South Korea.
Product overview
Human in Motion Robotics offers the XoMotion™ platform—a next-generation exoskeleton technology featuring a self-balancing, hands-free design for individuals with lower extremity motor deficits. The portfolio includes XoMotion-R for clinical ambulatory training at rehabilitation centers, future therapeutic recovery variants targeting stroke and neurological conditions, and planned personal mobility versions for daily home and community use. All variants share the core platform's advanced sensor systems and multi-modal controllers that enable physiological lower extremity motion.
Differentiator
Problem solved
Functional benefit
Brands
- XoMotion™: Next generation exoskeleton platform designed for individuals with lower extremity motor deficits. Features self-balancing, hands-free technology that mimics physiological motion of the lower extremity. Available in versions for ambulatory training (XoMotion-R), therapeutic recovery, and personal mobility.
Products and services
- XoMotion Next-generation self-balancing, hands-free exoskeleton platform designed for individuals with lower extremity motor deficits. Features advanced sensor systems and multi-modal controllers that allow users to perform complex mobility tasks by mimicking the physiological motion of the lower extremity.
- XoMotion-R Clinical version of the XoMotion platform designed for ambulatory training at rehabilitation centers. Specifically developed to help clinicians retrain spinal cord injury patients to stand upright and walk. Accommodates patients 5'0" to 6'4" in height and up to 220 lbs, with continuous use via hot-swappable battery.
- XoMotion Therapeutic Recovery Planned future variant of the XoMotion platform intended to serve a broader group of users seeking therapeutic benefit, including individuals recovering from stroke and other neurological conditions.
- XoMotion Personal Mobility Planned future variant of the XoMotion platform intended for daily personal use, enabling individuals with lower extremity motor deficits to independently perform mobility tasks at home and in their community.
Quantifiable outcome
- Available at rehabilitation centers starting early 2025
- +2 more outcomes
Companies that use Human in Motion Robotics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Human in Motion Robotics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Human in Motion Robotics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, foundational and supporting.
- Synaptic HealthcoreFirst commercial sale of XoMotion to Synaptic Health in Calgary, Canada. Synaptic Health operates as a rehabilitation center partner providing access to XoMotion technology for patients with mobility impairments.
- Simon Fraser UniversityfoundationalEarly self-balancing prototypes of XoMotion were created at Simon Fraser University by co-founders Dr. Park and Dr. Arzanpour. Academic collaboration foundation for the technology.
- Toyota Mobility Foundation / MaRSsupportingHMR participated in the Mobility Unlimited Hub, a collaboration between MaRS and the Toyota Mobility Foundation. This cohort-based program helps pre-growth stage personal mobility companies address challenges and scale solutions for people with disabilities through funding, resources, expert guidance, and community support.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Human in Motion Robotics competitors and assessment
Company assessmentDirect peers
- Ekso Bionics: Ekso Bionics develops and commercializes FDA-cleared wearable lower-limb exoskeletons (EksoGT, EksoNR) used in rehabilitation centers for stroke and spinal cord injury patients — directly competing with XoMotion-R in the same clinical ambulatory training use case.
- ReWalk Robotics: ReWalk is an FDA-cleared exoskeleton company with both clinical rehabilitation (ReStore) and personal mobility (ReWalk Personal 6.0) products for SCI and stroke patients — a direct competitor across HMR's XoMotion-R and future personal mobility roadmap.
- Parker Hannifin (Indego): Parker Hannifin's Indego exoskeleton offers FDA-cleared powered lower-limb exoskeletons for clinical and personal use by individuals with spinal cord injury — competing head-to-head with XoMotion across clinical rehab and personal mobility segments.
- Cyberdyne: Cyberdyne manufactures the HAL (Hybrid Assistive Limb) lower-limb exoskeleton for clinical rehabilitation and personal use, primarily in Japan — competing with HMR in SCI/stroke gait assistance, particularly relevant given HMR's APAC ambitions.
Emerging players
- Wandercraft: Wandercraft is developing the Atalante self-balancing lower-limb exoskeleton for personal mobility in SCI and stroke patients — the most direct technological analogue to XoMotion's self-balancing architecture and a clear emerging peer.
- Bionik Laboratories: Bionik Laboratories produces the InMotion ARM and is developing lower-limb robotic rehabilitation technologies for clinical use — overlapping with HMR's clinical rehabilitation center customer base and GTM motion.
- Rex Bionics: Rex Bionics develops the REX self-balancing robotic exoskeleton for hands-free mobility in individuals with mobility impairments — a direct technological analogue to XoMotion's self-balancing, hands-free positioning.
Broad incumbents
- SuitX (Ottobock): SuitX, acquired by Ottobock, developed the MAX modular exoskeleton for industrial and medical applications; Ottobock is a global prosthetics and orthotics incumbent that competes across the broader mobility-assistive device category relevant to HMR.
- Honda Walking Assist: Honda has developed the Walking Assist Device, a lower-limb exoskeleton for gait training and rehabilitation in clinical settings — a broad incumbent with overlapping rehabilitation center use cases and global distribution.
Others
- Toyota Mobility Foundation: Toyota Mobility Foundation is an existing HMR partner via the MaRS Mobility Unlimited Hub; as a major funder of personal mobility startups, it represents both an ecosystem enabler and a competitive backer of adjacent exoskeleton/mobility ventures.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Human in Motion Robotics social profiles
Digital presenceHuman in Motion Robotics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Human in Motion Robotics leadership team
Management profileNumber of profiles
Profiles7 records
Human in Motion Robotics funding detail
Funding detailFunding overview
Funding rounds6 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Human in Motion Robotics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Human in Motion Robotics
What does Human in Motion Robotics do?
Human in Motion Robotics designs, develops, and manufactures the XoMotion platform — a next-generation, self-balancing, hands-free lower-limb exoskeleton for individuals with lower extremity motor deficits. The clinical version (XoMotion-R) is sold to rehabilitation centers for ambulatory training of spinal cord injury patients, with future variants planned for therapeutic recovery and daily personal mobility. The company operates from Vancouver, Canada and Seoul, South Korea.
Is Human in Motion Robotics a public or private company?
Human in Motion Robotics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Human in Motion Robotics founded?
Human in Motion Robotics was founded in 2016. It employs 51 to 100 people.
Where is Human in Motion Robotics based?
Human in Motion Robotics is headquartered in Vancouver, Canada, in the North America region.
How does Human in Motion Robotics make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are future Personal Mobility Device Sales.
Who are Human in Motion Robotics's main competitors?
Direct peers on record are Ekso Bionics, ReWalk Robotics, Parker Hannifin (Indego) and Cyberdyne. Emerging players are Wandercraft, Bionik Laboratories and Rex Bionics. Broad incumbents are SuitX (Ottobock) and Honda Walking Assist. Toyota Mobility Foundation is listed as an others.
Does Human in Motion Robotics have an API?
No public API is recorded for Human in Motion Robotics.
What industry is Human in Motion Robotics in?
Human in Motion Robotics's product category is Medical Exoskeletons. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.